John Prendergast | Chairman
Recce Pharmaceuticals

John Prendergast, Chairman, Recce Pharmaceuticals

Dr. Prendergast, based in the US, is a renowned executive in the pharmaceutical industry. Currently serving as the Chairman and Co-founder of Palatin Technologies, Inc. (NYSE: PTN) and the Lead Director of Nighthawk Biosciences (NYSE: HHWK), he brings over three decades of expertise in the commercialisation of pharmaceutical technologies. Dr. Prendergast has lead the approval of three new drug applications and played a pivotal role in the successful sale of Vylessi® to Cosette Pharmaceuticals for USD $12M, marking a significant achievement in the pharmaceutical landscape.

Appearances:



Day 1 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:20

Presentation: To be announced

Sponsored by Recce Pharmaceuticals 

last published: 12/Jun/24 19:45 GMT
last published: 12/Jun/24 19:45 GMT

back to speakers


GET INVOLVED AT THE

WORLD ANTIMICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Justin Franks

justin.franks@terrapinn.com
+1 914 819 3506

 

To Speak


Kaylee Nguyen

kaylee.nguyen@terrapinn.com

 

 

Press & Media Partnerships

 


Kaylie Brogan

kaylie.brogan@terrapinn.com

 

 

Start-Ups & Posters

 


Semen Sen

semen.sen@terrapinn.com
+1 646.619.1793